Formula-specific directory
Research blends need more scrutiny—not fewer questions.
Commercial blend names are not standardized chemical identities. Compare the listed components, ratios, finished-blend testing, and exact lot before treating two products as equivalent.
A blend name is not a specification.
The same name can refer to different component amounts, peptide forms, or fragments. These profiles describe catalog conventions and evidence gaps; they do not recommend a product or use.
Wolverine blend
BPC-157 + TB-500 / thymosin-beta-4-related material
A two-component commercial research blend generally combining BPC-157 with a TB-500-labeled material.
Open blend profileGLOW blend
GHK-Cu + BPC-157 + TB-500 / thymosin-beta-4-related material
A three-component commercial research blend commonly labeled as GHK-Cu, BPC-157, and TB-500.
Open blend profileKLOW blend
GHK-Cu + BPC-157 + TB-500 / thymosin-beta-4-related material + KPV
A four-component commercial research blend that generally adds KPV to the components marketed as GLOW.
Open blend profileCJC-1295 + Ipamorelin blend
CJC-1295 No DAC / modified GRF 1-29 + Ipamorelin
A two-component research blend pairing a GHRH-related peptide with a ghrelin-receptor agonist.
Open blend profileTesamorelin + Ipamorelin blend
Tesamorelin + Ipamorelin
A commercial research blend combining a stabilized GHRH analog with a ghrelin-receptor agonist.
Open blend profileTriad-GH blend
Tesamorelin + Ipamorelin + CJC-1295 No DAC / modified GRF 1-29
A three-component commercial blend assembled from peptides associated with endocrine-signaling research.
Open blend profileCoremend blend
TB-500 / thymosin-beta-4-related material + BPC-157 + KPV
A commercial three-component preparation combining TB-500-labeled material, BPC-157, and KPV.
Open blend profileDeadpool blend
Cartalax + BPC-157 + TB-500 / thymosin-beta-4-related material
A supplier-specific blend combining Cartalax with BPC-157 and a TB-500-labeled material.
Open blend profileMito-Genesis blend
NAD+ + MOTS-c + 5-Amino-1MQ
A supplier-specific multi-compound research preparation combining a peptide, a coenzyme, and a small molecule.
Open blend profile